Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × encorafenib × Clear all

NCT04390243 2024-05-06

Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation

Phase 2 Terminated

6 enrolled 16 charts

Gastrointestinal

Pancreatic Neoplasms